| 来源类型 | Commentary |
| 规范类型 | 评论 |
| Drug Prices: U.S. Patients Not First | |
| Vivian Ho; Hagop M. Kantarjian | |
| 发表日期 | 2018-07-02 |
| 出版年 | 2018 |
| 语种 | 英语 |
| 概述 | The Trump administration's "American Patients First" plan is a green light for drug companies to continue their unfettered pricing schemes ... |
| 摘要 | The Trump administration's "American Patients First" plan is a green light for drug companies to continue their unfettered pricing schemes write the authors, who offer three steps to lower prescription drug prices in the U.S. The Hill: https://bit.ly/2KJuQt7 |
| 主题 | Center for Health and Biosciences |
| URL | https://www.bakerinstitute.org/research/american-patients-are-not-first/ |
| 来源智库 | James A. Baker III Institute for Public Policy (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/80320 |
| 推荐引用方式 GB/T 7714 | Vivian Ho,Hagop M. Kantarjian . Drug Prices: U.S. Patients Not First. 2018. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
